New Drug Development & Regulatory News
unoL Shutterstock
Domain Therapeutics progresses drug candidate for inflammatory diseases
Domain Therapeutics has announced it has nominated and is progressing DT-9046, a candidate with "game-changing" potential in multiple inflammatory disease markets.
21 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Love Employee Shutterstock
Sapio Sciences integrates NVIDIA BioNeMo for AI-driven drug discovery
Sapio Sciences, the science-aware lab informatics platform, has announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform.
20 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Libin Jose Shutterstock
BrePco Biopharma and Piramal Critical Care announce MHRA approval
BrePco Biopharma (BPCO) and Piramal Critical Care (PCC) has announced that the MHRA issued a grant of a Marketing Authorisation for the use of Neoatricon.
19 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
IChemE
House of Lords report includes IChemE recommendation
The House of Lords Science and Technology Committee report on engineering biology has included several recommendations put forward by The Institution of Chemical Engineers (IChemE), highlighting critical areas for advancing the field in the UK.
18 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
BGS
BGS US facility achieves initial quality certifications
BGS US recently acquired quality certifications for ISO 13485 and ISO 9001, and the confirmation of ISO 11137 for its 100,000- square-foot Electron Beam (E-Beam) sterilisation facility in Imperial, PA. The facility will begin operations in mid-2025.
11 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
ilikeyellow Shutterstock
Icotrokinra results show potential to for treatment in plaque psoriasis
Johnson & Johnson has announced new icotrokinra (JNJ2113) data from its comprehensive Phase 3 clinical programme and the start of the first head-to-head study in plaque psoriasis (Pso) seeking to demonstrate the superiority of an oral pill.
10 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Sorry, no results.
Love Employee Shutterstock
Sapio Sciences integrates NVIDIA BioNeMo for AI-driven drug discovery
Sapio Sciences, the science-aware lab informatics platform, has announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform.
20 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Libin Jose Shutterstock
BrePco Biopharma and Piramal Critical Care announce MHRA approval
BrePco Biopharma (BPCO) and Piramal Critical Care (PCC) has announced that the MHRA issued a grant of a Marketing Authorisation for the use of Neoatricon.
19 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
IChemE
House of Lords report includes IChemE recommendation
The House of Lords Science and Technology Committee report on engineering biology has included several recommendations put forward by The Institution of Chemical Engineers (IChemE), highlighting critical areas for advancing the field in the UK.
18 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
EyeVision Software
Quality control in the pharmaceutical industry
With increasing regulatory requirements and the need for full traceability, manufacturers are turning to advanced technologies like EyeVision Software to streamline quality control processes.
21 Mar 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
unoL Shutterstock
Domain Therapeutics progresses drug candidate for inflammatory diseases
Domain Therapeutics has announced it has nominated and is progressing DT-9046, a candidate with "game-changing" potential in multiple inflammatory disease markets.
21 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Mareks Perkons Shutterstock
LCP Health Analytics launches new Medicines Oracle tool
LCP has developed a new platform, Medicines Oracle, that will aid in understanding how medicines are used across the NHS.
21 Mar 2025
LogiPharma
CCT and Tower Cold Chain unite to unveil product launch at LogiPharma
Cold Chain Technologies (CCT) and Tower Cold Chain are set to make their biggest appearance yet at LogiPharma 2025, taking place in Lyon from 8-10th April.
21 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Carrier Global
Carrier launches Lynx FacTOR
Carrier Global Corporation announces the launch of Carrier Lynx FacTOR, a software-as-a-service (SaaS) solution designed to transform product release processes in the pharmaceutical industry.
20 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Beckman Coulter Life Sciences
Beckman Coulter Life Sciences launches modular spectral flow cytometry solution
Beckman Coulter Life Sciences and an Operating Company of Danaher Corporation, "revolutionises" spectral flow cytometry with the industry’s first modular solution: the CytoFLEX mosaic Spectral Detection Module.
20 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sorry, no results.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00